Manitoba returns to the private agencies it dropped as it struggles to fill nursing shifts
  • Jan 21, 2026

Manitoba returns to the private agencies it dropped as it struggles to fill nursing shifts

  • CBC News
The quiet commercialization of primary care records
  • Jan 21, 2026

The quiet commercialization of primary care records

  • Healthy Debate
  •  — 
  • Danyaal Raza
Novavax signs licensing agreement with Pfizer for vaccine development
  • Jan 20, 2026

Novavax signs licensing agreement with Pfizer for vaccine development

  • Reuters
GSK Grows in Immunology, Buying Rapt Therapeutics and Food Allergy Drug in $2.2B Deal
  • Jan 20, 2026

GSK Grows in Immunology, Buying Rapt Therapeutics and Food Allergy Drug in $2.2B Deal

  • MedCity News
Bristol Myers partners with Microsoft for AI-driven lung cancer detection
  • Jan 20, 2026

Bristol Myers partners with Microsoft for AI-driven lung cancer detection

  • Reuters
'Everyone told me I was crazy': Inside Calgary's massive psychedelics drug lab
  •  —
  • Jan 19, 2026

'Everyone told me I was crazy': Inside Calgary's massive psychedelics drug lab

  • Calgary Herald
Simple blood test can predict which breast cancer treatment will work best, study finds
  • Jan 19, 2026

Simple blood test can predict which breast cancer treatment will work best, study finds

  • The Guardian
The Carney government is about to give up a vital bit of sovereignty. Worse, it could harm Canadians’ health
  • Jan 18, 2026

The Carney government is about to give up a vital bit of sovereignty. Worse, it could harm Canadians’ health

  • Toronto Star
  •  — 
  • Matthew Herder
"I am very annoyed": Pharma execs blast RFK Jr.'s attack on vaccines
  • Jan 16, 2026

"I am very annoyed": Pharma execs blast RFK Jr.'s attack on vaccines
Sanofi sees near-term weakness in US vaccines sales due to antivax rhetoric
  • Jan 16, 2026

Sanofi sees near-term weakness in US vaccines sales due to antivax rhetoric

  • Reuters
US FDA delays two drug reviews in new expedited review program after safety, efficacy concerns
  • Jan 16, 2026

US FDA delays two drug reviews in new expedited review program after safety, efficacy concerns

  • Reuters
Food companies are targeting users of weight-loss drugs with 'GLP-1 Friendly' labels
  • Jan 14, 2026

Food companies are targeting users of weight-loss drugs with 'GLP-1 Friendly' labels

  • Associated Press
FDA tells pharma companies to remove suicide warnings from popular weight-loss drugs
  • Jan 13, 2026

FDA tells pharma companies to remove suicide warnings from popular weight-loss drugs

  • Associated Press
Nvidia, Eli Lilly to spend $1 billion over five years on joint research lab
  • Jan 13, 2026

Nvidia, Eli Lilly to spend $1 billion over five years on joint research lab

  • Reuters
Thermo Fisher wins contracts as pharma shifts production to US, CEO says
  • Jan 13, 2026

Thermo Fisher wins contracts as pharma shifts production to US, CEO says

  • Reuters
  • Jan 13, 2026

New drug candidate reverses metabolic liver disease and fibrosis, pre-clinical data show

  • McMaster University
'It predicts if somebody is going to die:’ How AI is changing healthcare in Canada
  • Jan 12, 2026

'It predicts if somebody is going to die:’ How AI is changing healthcare in Canada

  • CTV News
  • Jan 12, 2026

Basecamp Research launches world-first AI models for programmable gene insertion

  • CISION
Price of semaglutide drugs may drop more than half in Canada
  • Jan 12, 2026

Price of semaglutide drugs may drop more than half in Canada

  • Toronto Star
J&J strikes deal with US government to cut drug prices, gain tariff exemptions
  • Jan 09, 2026

J&J strikes deal with US government to cut drug prices, gain tariff exemptions

  • Reuters
OpenAI launches 'ChatGPT Health'
  • Jan 08, 2026

OpenAI launches 'ChatGPT Health'

  • Reuters
Canadians with celiac disease want Ottawa to help lower grocery prices
  •  —
  • Jan 08, 2026

Canadians with celiac disease want Ottawa to help lower grocery prices

  • The Globe and Mail
Trump administration cannot proceed with pilot drug rebate program, US court rules
  • Jan 08, 2026

Trump administration cannot proceed with pilot drug rebate program, US court rules

  • Reuters
Artificial intelligence begins prescribing medications in Utah
  • Jan 07, 2026

Artificial intelligence begins prescribing medications in Utah

  • POLITICO
Manitoba cuts ties with dozens of private nursing agencies to curb reliance on the firms
  • Jan 07, 2026

Manitoba cuts ties with dozens of private nursing agencies to curb reliance on the firms

  • CBC News
Insurance lobbyists ramped up 'pressure campaign' against pharmacare ahead of federal budget: Council of Canadians
  • Jan 07, 2026

Insurance lobbyists ramped up 'pressure campaign' against pharmacare ahead of federal budget: Council of Canadians

  • NB Media Co-op
Is Trump lowering drug prices? What to know for his Trump's second term
  • Jan 07, 2026

Is Trump lowering drug prices? What to know for his Trump's second term

  • Axios
Bayer sues Moderna, J&J and Pfizer/BioNTech over COVID vax tech
  • Jan 07, 2026

Bayer sues Moderna, J&J and Pfizer/BioNTech over COVID vax tech

  • Fierce Pharma
U.S. Companies Are Selling Tests for Autism, but Research Is Still Scant
  •  —
  • Jan 07, 2026

U.S. Companies Are Selling Tests for Autism, but Research Is Still Scant

  • The New York Times
Novo Nordisk Canada considers competing with generics through renamed lower-price Ozempic
  • Jan 07, 2026

Novo Nordisk Canada considers competing with generics through renamed lower-price Ozempic

  • CityNews
MAVIRET receives Health Canada Approval for the Treatment of Acute Hepatitis C Virus
  • Jan 07, 2026

MAVIRET receives Health Canada Approval for the Treatment of Acute Hepatitis C Virus

  • CISION
Novo Nordisk prepares new cheaper version of Ozempic as generics face delays
  •  —
  • Jan 06, 2026

Novo Nordisk prepares new cheaper version of Ozempic as generics face delays

  • The Globe and Mail
Novo Nordisk launches Wegovy weight-loss pill in US, triggering price war
  • Jan 06, 2026

Novo Nordisk launches Wegovy weight-loss pill in US, triggering price war

  • The Guardian
More than 40 million worldwide turn to ChatGPT for health questions
  • Jan 06, 2026

More than 40 million worldwide turn to ChatGPT for health questions

  • Axios
This Medical Device Is a Chronic Pain Game-Changer
  • Jan 06, 2026

This Medical Device Is a Chronic Pain Game-Changer

  • The Tyee
Montreal start-up develops airbag-equipped pants designed to reduce hip fractures in seniors
  • Jan 04, 2026

Montreal start-up develops airbag-equipped pants designed to reduce hip fractures in seniors

  • CTV News
Kids are using these illegal caffeine packages. Why doctors say it’s alarming
  • Jan 04, 2026

Kids are using these illegal caffeine packages. Why doctors say it’s alarming

  • Toronto Star
'Chinese Peptides' Are the Latest Biohacking Trend in the Tech World
  • Jan 04, 2026

'Chinese Peptides' Are the Latest Biohacking Trend in the Tech World

  • The New York Times
Generic Ozempic can be made in Canada as of next week, but don’t expect to get it soon
  • Jan 02, 2026

Generic Ozempic can be made in Canada as of next week, but don’t expect to get it soon

  • CTV News
Hamilton hospital employs new tech to track down misplaced equipment
  •  —
  • Jan 02, 2026

Hamilton hospital employs new tech to track down misplaced equipment

  • The Globe and Mail
How an Ontario chronic pain clinic is taking a new approach for long-lasting relief
  •  —
  • Jan 01, 2026

How an Ontario chronic pain clinic is taking a new approach for long-lasting relief

  • The Globe and Mail
What to watch for in weight loss drugs in 2026
  • Jan 01, 2026

What to watch for in weight loss drugs in 2026

  • NBC News

Get Canada’s essential briefing on health policy, science, and system change.  Get Briefing